Keynote Speakers
Bernhard Weigl
Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund | 
Lidong Qin
Professor and CPRIT Scholar, Houston Methodist Research Institute | 
James Heath
Elizabeth W. Gilloon Professor of Chemistry, California Institute of Technology (CalTech) | 
Aaron Wheeler
Canada Research Chair of Bioanalytical Chemistry, University of Toronto | 
Minetta Liu
Associate Professor and Chair, Oncology Research, Mayo Clinic | 
Jason Heikenfeld
Professor and VP Operations, UC Office of Innovation, University of Cincinnati |
|
Jennifer Friedman
Clinical Professor of Neurosciences and Pediatrics, Rady Children's Hospital in San Diego | 
Tingrui Pan
Professor, Department of Biomedical Engineering, University of California-Davis | 
Alan Wright
Chief Medical Officer, Roche Diagnostics Corporation | 
Alexander Asanov
Chief Scientific Officer, TIRF Labs, Inc. | 
Gary Schroth
Vice President and Distinguished Scientist, Illumina | 
Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas | 
Kamlesh Patel
R&D Advanced System Engineering and Deployment Manager, Sandia National Laboratories | 
Gary Siuzdak
Professor and Director, The Scripps Research Institute | 
Juan Santiago
Charles Lee Powell Foundation Professor, Stanford University | 
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos | 
Abraham Lee
Chancellor’s Professor, Biomedical Engineering & Director, Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine | 
Weian Zhao
Associate Professor, Department of Biomedical Engineering, University of California-Irvine |
Overview
This conference brings together technology development and applications of: - Next-Generation Sequencing (NGS)
- Single Cell Analysis (SCA)
- Single Molecule Analysis (SMA)
- Mass Spectrometry
Technology
development in these fields is occurring in parallel with advances in
Lab-on-a-Chip/Microfluidics and the broader push in diagnostics
development, and in this vein this conference is co-located and
concurrent with the following conferences at the same venue and at
the same time: 1. Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications
2. Lab-on-a-Chip and Microfluidics: Techologies and Commercialization
3. Point-of-Care Diagnostics & Global Health World Congress 2016
4.
Next-Generation Sequencing (NGS), Single-Cell Analysis (SCA), Single
Molecule Analysis (SMA) & Mass Spectrometry: Research to Diagnostics
2016It
has become increasingly apparent that the differences between cells in
the same population can be significant, and there is therefore a need
for improved methods to capture and analyze individual cells such as
circulating tumor cells (CTCs). The
development of technologies for single cell analysis (SCA) is driving
this field forward via basic research on isolated individual
cells, the development of biomarker assays, and diagnostics development. We
also explore at this conference the translation of next-generation
sequencing (NGS) from research to deployment in the clinical-setting for
oncology, genetic testing, as well as infectious disease testing. As
NGS permeates the cancer biomarker and genetic testing realms and cost
of NGS declines, there is the opportunity and hope to deploy NGS as a
means to personalize diagnostics and therapeutics -- this is one of the
themes explored in the NGS section of this conference. This
conference will also present the latest technologies/products in flow
cytometry, FISH, immunoma
Session Sponsors
Agenda Topics- Flow Cytometry, FISH and Technologies for Single Cell Analysis (SCA)
- Front-end Sample Preparation for NGS -- Challenges with Clinic Samples
- Microfluidic Devices for Single Cell Analysis (SCA)
- NGS in Non-Invasive Prenatal Testing (NIPT)
- NGS on Rare Cells (such as Circulating Tumor Cells)
- Sample Preparation for Mass Spectrometry — Challenges Posed by Clinical Samples and the Need for Robustness, Scale and Automation for Diagnostics
- LC/MS for Clinical Diagnostics
- Mass Spectrometry for Biofluid Biomarker Analysis
- Single Cell Analysis (SCA) and Single Molecule Analysis (SMA) for Diagnostics Development and Genetic, Prenatal Testing
- Single Cell Analysis (SCA) and Single Molecule Analysis (SMA) in Cancer, CNS Diseases, and Other Disease Classes
- Single Cell Transcriptomics and Proteomics
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateLyle Arnold, Chief Scientific Officer, Biocept
Nazneen Aziz, Executive Director, Kaiser Permanente Research Bank
Rajiv Bharadwaj, Director, Microfluidics, 10x Genomics
Utkan Demirci, Professor, Stanford University School of Medicine
Naside Gozde Durmus, Research Scientist, Stanford University
Grant Howes, Vice President, Commercial Operations , Celsee Diagnostics
Eric Kaldjian, Chief Medical Officer, RareCyte
Erick Lin, Director of Medical Affairs, Ambry Genetics
Yu-Hwa Lo, Professor, University of California San Diego
John Nolan, CEO, Cellarcus Biosciences, Inc.
Martin Siaw, Vice President of Science and Innovation, BasePrime Genomics
Kendall Van Keuren-Jensen, Professor and Deputy Director, Translational Genomics Research Institute
Charles Wang, Director & Professor, Loma Linda University
Chris Wetzel, Director of Sales and Marketing, MMI Microscope-based Single Cell Isolation
Yong Zeng, Associate Professor, University of Florida
Kun Zhang, Professor, Department of Bioengineering, University of California San Diego
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2016-09-26 00:00:002016-09-28 00:00:00Europe/LondonNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016NGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
